
Bayer CropScience Ltd is Rated Sell
2026-01-20 10:10:43Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Bayer CropScience Ltd Technical Momentum Shifts Amid Bearish Signals
2026-01-14 08:01:36Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 0.33%, the stock’s broader technical landscape reveals cautionary signals, underscoring challenges ahead for investors in the pesticides and agrochemicals sector.
Read full news article
Bayer CropScience Ltd is Rated Sell
2026-01-09 10:10:44Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Bayer CropScience Ltd is Rated Sell
2025-12-29 10:10:52Bayer CropScience Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 Oct 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Bayer CropSci. Sees Revision in Market Evaluation Amidst Challenging Financial Trends
2025-12-18 10:10:41Bayer CropSci., a smallcap player in the Pesticides & Agrochemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued growth and valuation concerns, impacting investor sentiment and stock performance.
Read full news article
Bayer CropSci. Sees Revision in Market Evaluation Amid Challenging Financial Trends
2025-11-27 10:06:18Bayer CropSci., a small-cap player in the Pesticides & Agrochemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued growth and valuation concerns, prompting a reassessment of the company’s standing within its industry.
Read full news articleWhy is Bayer CropSci. falling/rising?
2025-11-11 22:56:39As of 11-Nov, Bayer CropScience Ltd is experiencing a decline in its stock price, currently at Rs 4,506.85, which reflects a decrease of 131.1 points or 2.83%. The stock has underperformed its sector by 2.4% today, touching an intraday low of Rs 4,490, which is a drop of 3.19%. Over the past week, the stock has seen a return of -6.81%, and its performance over the last month is also negative at -9.92%. Despite a rise in investor participation, with delivery volume increasing by 90.59% against the 5-day average, the stock is trading below all key moving averages, indicating a bearish trend. Additionally, the company has shown poor long-term growth, with operating profit declining at an annual rate of -3.22% over the last five years, and recent financial results have been flat, contributing to the negative sentiment surrounding the stock. In the broader market context, Bayer CropScience's performance contras...
Read full news articleHow has been the historical performance of Bayer CropSci.?
2025-11-09 22:41:31Answer: The historical performance of Bayer CropSci. shows a trend of increasing net sales and operating income over the years, with net sales reaching 5,473.40 Cr in March 2025, up from 5,106.20 Cr in March 2024 and 5,139.70 Cr in March 2023. However, operating profit (PBDIT) has seen a decline from 1,035.00 Cr in March 2024 to 809.30 Cr in March 2025. Profit before tax also decreased to 707.40 Cr in March 2025 from 941.40 Cr in March 2024, while profit after tax fell to 568.00 Cr from 740.50 Cr in the same period. The company's total assets increased to 5,236.20 Cr in March 2025, compared to 4,597.10 Cr in March 2024, indicating growth in the asset base. Total liabilities also rose to 5,236.20 Cr from 4,597.10 Cr, reflecting an increase in financial obligations. Cash flow from operating activities decreased significantly to 262.00 Cr in March 2025 from 951.00 Cr in March 2024, contributing to a net cash o...
Read full news articleAre Bayer CropSci. latest results good or bad?
2025-11-08 19:19:58Bayer CropScience's latest financial results for Q2 FY26 highlight significant operational trends, particularly influenced by the seasonal nature of the agrochemicals business. The company reported net sales of ₹1,914.60 crores, reflecting a substantial sequential increase of 82.97% from the previous quarter, driven by heightened demand during the kharif sowing season. Year-on-year, revenue growth stood at 17.36%, indicating resilience in maintaining market share amidst competitive pressures. Net profit for the same quarter reached ₹278.70 crores, which is a notable increase of 94.50% quarter-on-quarter and 9.64% year-on-year. However, despite these positive profit figures, the operating margin experienced compression, standing at 18.20%. This represents a sequential improvement but a decline compared to the previous year, suggesting challenges in maintaining profitability amidst rising costs or competitiv...
Read full news articleBayer Cropscience Limited - Other General Purpose
24-Sep-2019 | Source : NSEBayer Cropscience Limited has informed the Exchange regarding Notice Published in the Newspaper.
Copy of Newspaper Publication
23-Sep-2019 | Source : NSE
| Bayer Cropscience Limited has informed the Exchange regarding Notice Published in the Newspaper. |
News Verification
09-Oct-2013 | Source : NSE
| News Verification : The media had reports that "Bayer in Talks to buy into Kaveri Seeds". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Bayer Cropscience Limited has vide its letter inter-alia stated, "The Company will not comment on market rumours." |
Corporate Actions
No Upcoming Board Meetings
Bayer CropScience Ltd has declared 900% dividend, ex-date: 14 Nov 25
No Splits history available
No Bonus history available
No Rights history available






